<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-AGZWJKW7</identifier><date>2013</date><creator>Blamek, Sławomir</creator><relation>documents/doc/A/URN_NBN_SI_doc-AGZWJKW7_001.pdf</relation><relation>documents/doc/A/URN_NBN_SI_doc-AGZWJKW7_001.txt</relation><format format_type="issue">1</format><format format_type="volume">47</format><format format_type="type">article</format><format format_type="extent">str. 50-56, IV</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">269053952</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-AGZWJKW7</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">arteriovenske malformacije</subject><subject language_type_id="slv">možgani</subject><subject language_type_id="slv">onkologija</subject><subject language_type_id="slv">radiološko zdravljenje</subject><subject language_type_id="slv">radioterapija</subject><title>Hypofractionated stereotactic radiotherapy for large or involving critical organs cerebral arteriovenous malformations</title></Record>